Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
First TAVR for Aortic Regurgitation Moves to Phase 3 Trial
WASHINGTON — A phase 3 randomized trial will soon begin for the first transcatheter aortic valve replacement (TAVR) device for the treatment of aortic valve regurgitation after promising results in a 2-year initial study. If this novel option performs as…
English